248 related articles for article (PubMed ID: 23345334)
1. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.
Wang Z; Liu JQ; Liu Z; Shen R; Zhang G; Xu J; Basu S; Feng Y; Bai XF
J Immunol; 2013 Mar; 190(5):2415-23. PubMed ID: 23345334
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
Lu R; Kujawski M; Pan H; Shively JE
Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.
Hayata K; Iwahashi M; Ojima T; Katsuda M; Iida T; Nakamori M; Ueda K; Nakamura M; Miyazawa M; Tsuji T; Yamaue H
PLoS One; 2013; 8(1):e53131. PubMed ID: 23372655
[TBL] [Abstract][Full Text] [Related]
4. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.
Lengagne R; Pommier A; Caron J; Douguet L; Garcette M; Kato M; Avril MF; Abastado JP; Bercovici N; Lucas B; Prévost-Blondel A
PLoS One; 2011; 6(5):e20235. PubMed ID: 21633700
[TBL] [Abstract][Full Text] [Related]
5. Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.
Iannone R; Miele L; Maiolino P; Pinto A; Morello S
Neoplasia; 2013 Dec; 15(12):1400-9. PubMed ID: 24403862
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
[TBL] [Abstract][Full Text] [Related]
7. Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.
Bartkowiak T; Jaiswal AR; Ager CR; Chin R; Chen CH; Budhani P; Ai M; Reilley MJ; Sebastian MM; Hong DS; Curran MA
Clin Cancer Res; 2018 Mar; 24(5):1138-1151. PubMed ID: 29301830
[No Abstract] [Full Text] [Related]
8. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice.
Marttila-Ichihara F; Castermans K; Auvinen K; Oude Egbrink MG; Jalkanen S; Griffioen AW; Salmi M
J Immunol; 2010 Mar; 184(6):3164-73. PubMed ID: 20154208
[TBL] [Abstract][Full Text] [Related]
9. Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response.
Yang J; Hawkins OE; Barham W; Gilchuk P; Boothby M; Ayers GD; Joyce S; Karin M; Yull FE; Richmond A
Cancer Res; 2014 Dec; 74(24):7274-84. PubMed ID: 25336190
[TBL] [Abstract][Full Text] [Related]
10. The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.
Wagner KD; Cherfils-Vicini J; Hosen N; Hohenstein P; Gilson E; Hastie ND; Michiels JF; Wagner N
Nat Commun; 2014 Dec; 5():5852. PubMed ID: 25510679
[TBL] [Abstract][Full Text] [Related]
11. Deletion of MyD88 in T Cells Improves Antitumor Activity in Melanoma.
Bayer AL; Padilla-Rolon D; Smolgovsky S; Hinds PW; Alcaide P
Am J Pathol; 2024 Jun; 194(6):1007-1019. PubMed ID: 38442804
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Receptor-1 (p55) Deficiency Attenuates Tumor Growth and Intratumoral Angiogenesis and Stimulates CD8
Rodriguez YI; Campos LE; Castro MG; Bannoud N; Blidner AG; Filippa VP; Croci DO; Rabinovich GA; Alvarez SE
Cells; 2020 Nov; 9(11):. PubMed ID: 33202705
[TBL] [Abstract][Full Text] [Related]
13. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors.
Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M
Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345
[TBL] [Abstract][Full Text] [Related]
14. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
15. Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy.
Wang L; Liu JQ; Talebian F; El-Omrani HY; Khattabi M; Yu L; Bai XF
Eur J Immunol; 2010 Sep; 40(9):2569-79. PubMed ID: 20662098
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
[TBL] [Abstract][Full Text] [Related]
17. IL-32γ potentiates tumor immunity in melanoma.
Gruber T; Kremenovic M; Sadozai H; Rombini N; Baeriswyl L; Maibach F; Modlin RL; Gilliet M; von Werdt D; Hunger RE; Seyed Jafari SM; Parisi G; Abril-Rodriguez G; Ribas A; Schenk M
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841222
[TBL] [Abstract][Full Text] [Related]
18. Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity.
Kaimala S; Mohamed YA; Nader N; Issac J; Elkord E; Chouaib S; Fernandez-Cabezudo MJ; Al-Ramadi BK
Cancer Immunol Immunother; 2014 Jun; 63(6):587-99. PubMed ID: 24668365
[TBL] [Abstract][Full Text] [Related]
19. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.
Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF
Eur J Immunol; 2013 Feb; 43(2):468-79. PubMed ID: 23225163
[TBL] [Abstract][Full Text] [Related]
20. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
